The Board of Directors of Advent Pharma Ltd. recommended 2% Cash Dividend for the year ended June 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 BDT | -1.16% |
|
+0.79% | +2.81% |
1st Jan change | Capi. | |
---|---|---|
+2.81% | 2.03Cr | |
-12.56% | 7.91TCr | |
-5.37% | 713.1Cr | |
+25.38% | 357.99Cr | |
-6.12% | 292.8Cr | |
+14.19% | 169.31Cr | |
-7.71% | 118.79Cr | |
-32.50% | 110.83Cr | |
-35.50% | 105.25Cr | |
-28.56% | 94Cr |
- Stock Market
- Equities
- ADVENT Stock
- News Advent Pharma Ltd.
- Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023